About this opportunity:
Freenome is seeking a Strategic Account Executive (Midwest) to help us redefine the landscape of early cancer detection by driving programmatic adoption of screening in health systems. The ideal candidate is proactive and driven and will be instrumental in adoption and implementation of Freenome’s early cancer detection tests, and digital health platform. The Strategic Account Executive will meet sales goals within the assigned geography by networking and building relationships with health systems and institutions. You will partner with the implementation team to ensure adoption of Freenome’s tests. The successful candidate will be assessed on quality and quantity of contracts in accordance with Freenome’s high performing standards.
The role will initially report to the Vice President of Sales. This role will be a Remote role within the Midwest and will require the ability to travel 50% of working time away from work location, may include overnight/weekend travel.
What you’ll do:
- Become a subject matter expert in Freenome’s technology and service offerings, effectively representing the company to key stakeholders including C-suite, executives, KOL physicians, Medical Directors, Hospital Administrators, Lab Directors, Precision Medicine Directors and Senior Management of Partner Labs
- Be an amazing sales person, effectively articulating the value of Freenome’s industry leading tests and digital health tools to executive and provider leadership within health systems
- Partner with Medical Affairs to educate and recruit Health Systems to utilize Freenome’s test
- Negotiate and close contracts with health systems and institutions
- Collaborate with both internal and external stakeholders in order to implement EMR and UX tools that will drive growth of Freenome’s test
- Capture information on customer interactions using CRM tools, including point of contact information, sales call activities, market intelligence, funnel development, and other data points
- Provide feedback to the Product and Marketing team directly from customers
- Structure detailed strategic plans for gaining and retaining health systems and institution contracts
- Identify market opportunities, monitor competitive activity, and present findings to commercial leadership
Must haves:
- Bachelor’s Degree in Sales, Business Management, Marketing or, Science, or any other related field
- 10+ years of medical sales experience and 3+ years with a strong record of success selling complex diagnostics solutions to health systems or institutions
- Experience with institutional sales successfully closing and implementing contracts with health systems
- Understanding of the healthcare system, reimbursement pathways, and screening protocols
- Strong communication, negotiation, and stakeholder engagement skills
- Strong presentation skills: ability to effectively convey concepts in a clear, concise, and professional manner through telephone and face-to-face interactions
- Experience with CRM tools and data-driven account planning
- Ability to sell technically complex products
- Possession of a valid driver's license
Nice to haves:
- Experience with liquid biopsy early cancer detection
- Demonstrated experience promoting digital health solutions to health systems
- Experience selling disruptive technologies and improving the standard of care
Benefits and additional information:
The US target range of our base salary for new hires is $175,000 - $210,000. You will also be eligible to receive equity, cash bonuses, and a full range of medical, financial, and other benefits depending on the position offered. Please note that individual total compensation for this position will be determined at the Company’s sole discretion and may vary based on several factors, including but not limited to, location, skill level, years and depth of relevant experience, and education. We invite you to check out our career page @ freenome.com/job-openings/ for additional company information.
Freenome is proud to be an equal-opportunity employer, and we value diversity. Freenome does not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law.
Applicants have rights under Federal Employment Laws.
- Family & Medical Leave Act (FMLA)
- Equal Employment Opportunity (EEO)
- Employee Polygraph Protection Act (EPPA)
#LI-REMOTE
What We Do
Freenome is on a mission to empower everyone with the tools they need to detect, treat, and ultimately prevent cancer. We have pioneered the most comprehensive multiomics platform for early cancer detection through a routine blood draw. By combining deep expertise in molecular biology with advanced computational biology and machine learning techniques to recognize disease-associated patterns among billions of circulating, cell-free biomarkers, we are developing simple and accurate blood tests for early cancer detection and integrating the actionable insights into health systems to operationalize a machine learning feedback loop between care and science. Our recent $270 Million Series C brings our financing to over $500 million from investors, including; Bain Capital, Perceptive Advisors, RA Capital, Polaris Partners, Andreessen Horowitz, funds and accounts advised by T. Rowe Price Associates, Inc., GV (formerly Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society’s BrightEdge Ventures, Data Collective Venture Capital, Novartis and Verily Life Sciences.
